Summary
The intraocular lens market is projected to reach USD 6.17 billion by 2030 from USD 4.62 billion in 2025, at a CAGR of 6.0% during the forecast period.
https://mnmimg.marketsandmarkets.com/Images/intraocular-lens-market-img-overview.webp
The intraocular lens market is driven by the rising global prevalence of cataracts, a growing elderly population, and the increasing adoption of premium lenses that offer enhanced visual outcomes. However, high costs of advanced IOLs, reimbursement limitations, and unequal access to skilled ophthalmic care restrain broader uptake. Opportunities emerge from expanding healthcare infrastructure in emerging economies, rising demand for presbyopia-correcting and EDOF IOLs, and continuous innovations aimed at improving postoperative vision and reducing complications, creating strong growth potential across regions.
Based on type, aspheric monofocal IOLs hold the largest market share because they deliver dependable visual clarity, reduce spherical aberrations, and enhance contrast sensitivity at an affordable cost. Their broad surgeon acceptance, strong safety profile, and extensive reimbursement coverage make them the standard choice for routine cataract surgeries. Consistent global availability and proven long-term outcomes further reinforce their dominant market position.
Based on material, hydrophobic acrylic IOLs hold the largest market share due to their excellent biocompatibility, low rates of posterior capsular opacification, and strong long-term optical performance. Surgeons prefer them for their stability, reduced glistening, and high patient satisfaction. Their widespread availability, proven clinical outcomes, and suitability across both standard and premium IOL categories further reinforce their dominant position in the global IOLs market.
North America holds the largest market share in the IOLs market due to its high volume of cataract surgeries, advanced healthcare infrastructure, and strong adoption of premium technologies, such as toric, multifocal, and EDOF IOLs. Favorable reimbursement policies, a well-established network of skilled ophthalmic surgeons, and continuous innovation from leading manufacturers further support market dominance. Additionally, high patient awareness, early uptake of new devices, and substantial healthcare spending reinforce North America’s leading position globally.
A breakdown of the primary participants (supply side) for the intraocular lens market referred to in this report is provided below:
? By Company Type: Tier 1 (45%), Tier 2 (30%), and Tier 3 (25%)
? By Designation: C-level Executives (42%), Director-level Executives (29%), and Others (29%)
? By Region: North America (29%), Europe (24%), Asia Pacific (29%), Latin America (10%), Middle East & Africa (5%), and GCC Countries (3%)
Prominent players in the intraocular lens market are Alcon (US), Johnson & Johnson Vision Care, Inc. (US), Carl Zeiss Meditec AG (Germany), HOYA Corporation (Japan), Bausch + Lomb (US), Santen Pharmaceutical Co., Ltd. (Japan), NIDEK CO., LTD. (Japan), Lenstec, Inc. (US), Rayner Group (England), BVI (US), OPHTEC B.V. (Netherlands), SAV-IOL SA (Switzerland), Appasamy Associates Private Limited (India), Atia Vision, Inc. (US), and Biotech (Switzerland), among others.
Research Coverage
The report evaluates the intraocular lens market and estimates the market size and future growth potential of this market based on various segments, including material, type, application, end user, and region. The report also includes a competitive analysis of the major players in this market, along with company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will assist market leaders and new entrants with data on the nearest approximations of revenue numbers for the overall intraocular lens market and its subsegments. The report will help stakeholders understand the competitive landscape and gain further insights into better positioning their businesses and developing effective go-to-market strategies. The report helps stakeholders understand the market pulse and provides them with data on influential drivers, hindrances, obstacles, and opportunities in the market.
This report provides insights into the following points:
? Analysis of key drivers (increasing geriatric population, rising prevalence of eye disorders, technological advancements in ophthalmic devices, and increased government initiatives to control visual impairment), restraints (high cost of ophthalmology devices, high cost and risk associated with eye surgeries, and the rising adoption of refurbished ophthalmic devices), opportunities (potential growth opportunities in emerging markets and the low adoption of phacoemulsification devices and premium IOLs in emerging markets), and challenges (low accessibility to eye care in low-income countries and lack of skilled professionals)
? Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global intraocular lens market
? Market Development: Thorough knowledge and analysis of the profitable rising markets by type, material, application, end user, and region
? Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global intraocular lens market
? Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global intraocular lens market
ページTOPに戻る
Table of Contents
1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 26
1.3 STUDY SCOPE 26
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 26
1.3.2 INCLUSIONS AND EXCLUSIONS 27
1.3.3 YEARS CONSIDERED 27
1.4 CURRENCY CONSIDERED 28
1.5 STAKEHOLDERS 28
1.6 SUMMARY OF CHANGES 29
2 EXECUTIVE SUMMARY 30
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 30
2.2 KEY MARKET PARTICIPANTS: INSIGHTS AND STRATEGIC DEVELOPMENTS 31
2.3 DISRUPTIVE TRENDS SHAPING MARKET 32
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 33
2.5 SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 34
3 PREMIUM INSIGHTS 35
3.1 INTRAOCULAR LENS MARKET OVERVIEW 35
3.2 ASIA PACIFIC: INTRAOCULAR LENS MARKET 36
3.3 INTRAOCULAR LENS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 37
3.4 INTRAOCULAR LENS MARKET: REGIONAL MIX 37
3.5 INTRAOCULAR LENS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 38
4 MARKET OVERVIEW 39
4.1 INTRODUCTION 39
4.2 MARKET DYNAMICS 39
4.2.1 DRIVERS 40
4.2.1.1 Increasing geriatric population and subsequent rise in ophthalmic disorders 40
4.2.1.2 Rising number of cataract surgeries 40
4.2.1.3 Growing technological advancements in intraocular lens 42
4.2.2 RESTRAINTS 42
4.2.2.1 Rising cost of intraocular lenses 42
4.2.3 OPPORTUNITIES 43
4.2.3.1 High growth potential in emerging economies 43
4.2.4 CHALLENGES 43
4.2.4.1 Shortage of skilled ophthalmologists 43
4.3 UNMET NEEDS AND WHITE SPACES 44
4.3.1 UNMET NEEDS IN INTRAOCULAR LENS MARKET 44
4.3.2 WHITE SPACE OPPORTUNITIES 45
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 45
4.4.1 INTERCONNECTED MARKETS 45
4.4.2 CROSS-SECTOR OPPORTUNITIES 46
4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 46
5 INDUSTRY TRENDS 47
5.1 PORTER’S FIVE FORCES ANALYSIS 47
5.1.1 BARGAINING POWER OF BUYERS 48
5.1.2 BARGAINING POWER OF SUPPLIERS 48
5.1.3 THREAT OF NEW ENTRANTS 49
5.1.4 THREAT OF SUBSTITUTES 49
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 49
5.2 MACROECONOMIC OUTLOOK 49
5.2.1 INTRODUCTION 49
5.2.2 GDP TRENDS AND FORECAST 49
5.2.3 TRENDS IN GLOBAL OPHTHALMIC EQUIPMENT INDUSTRY 51
5.2.4 TRENDS IN GLOBAL CATARACT SURGERY INDUSTRY 51
5.3 SUPPLY CHAIN ANALYSIS 52
5.4 VALUE CHAIN ANALYSIS 53
5.5 ECOSYSTEM ANALYSIS 55
5.6 PRICING ANALYSIS 56
5.6.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 56
5.6.2 AVERAGE SELLING PRICE TREND, BY REGION 57
5.7 TRADE ANALYSIS 57
5.7.1 IMPORT SCENARIO (HS CODE 900290) 57
5.7.2 EXPORT DATA (HS CODE 900290) 58
5.8 KEY CONFERENCES AND EVENTS, 2025?2027 59
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 59
5.10 INVESTMENT AND FUNDING SCENARIO 60
5.11 CASE STUDY ANALYSIS 61
5.11.1 CASE STUDY 1: ENHANCED REFRACTIVE ACCURACY FOR POST-LASIK CATARACT PATIENTS 61
5.11.2 CASE STUDY 2: EXPANDING ACCESS TO CATARACT CARE IN LOW-INCOME REGIONS 61
5.11.3 CASE STUDY 3: DIGITAL WORKFLOW TRANSFORMATION FOR PREMIUM CATARACT SURGERY 62
5.12 IMPACT OF 2025 US TARIFF ON INTRAOCULAR LENS MARKET 62
5.12.1 INTRODUCTION 62
5.12.2 KEY TARIFF RATES 63
5.12.3 PRICE IMPACT ANALYSIS 64
5.12.4 IMPACT ON COUNTRY/REGION 64
5.12.4.1 North America 64
5.12.4.2 Europe 65
5.12.4.3 Asia Pacific 65
5.12.5 END-USE INDUSTRY IMPACT 65
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 66
6.1 KEY EMERGING TECHNOLOGIES 66
6.1.1 NEXT-GENERATION EDOF AND HYBRID OPTIC DESIGNS 66
6.1.2 AI-DRIVEN PERSONALIZED IOL PLANNING AND CALCULATION PLATFORMS 66
6.2 COMPLEMENTARY TECHNOLOGIES 67
6.2.1 ADVANCED BIOMETRY AND DIAGNOSTICS 67
6.3 TECHNOLOGY/PRODUCT ROADMAP 67
6.3.1 SHORT-TERM (2025?2027) | FOUNDATION & EARLY COMMERCIALIZATION 67
6.3.2 MID-TERM (2027?2030) | EXPANSION & STANDARDIZATION 68
6.3.3 LONG-TERM (2030?2035+) | MASS COMMERCIALIZATION & DISRUPTION 68
6.4 PATENT ANALYSIS 69
6.4.1 JURISDICTION AND TOP APPLICANT ANALYSIS 69
6.4.2 LIST OF PATENTS 70
6.5 FUTURE APPLICATIONS 71
6.5.1 POSTOPERATIVE ADJUSTABLE AND CUSTOMIZABLE INTRAOCULAR LENS 71
6.5.2 REGENERATIVE AND BIOINTEGRATIVE LENS TECHNOLOGIES 72
6.5.3 AI-INTEGRATED DIGITAL SURGICAL ECOSYSTEMS FOR INTRAOCULAR LENS 72
6.6 IMPACT OF AI/GEN AI ON INTRAOCULAR LENS MARKET 73
6.6.1 INTRODUCTION 73
6.6.2 TOP USE CASES AND MARKET POTENTIAL 73
6.6.3 CASE STUDIES OF AI IMPLEMENTATION IN INTRAOCULAR LENS MARKET 74
6.6.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 75
6.6.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN INTRAOCULAR LENS MARKET 75
7 SUSTAINABILITY AND REGULATORY LANDSCAPE 76
7.1 REGIONAL REGULATIONS AND COMPLIANCE 76
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
7.1.2 INDUSTRY STANDARDS 78
7.2 SUSTAINABILITY INITIATIVES 79
7.2.1 CARBON IMPACT AND ECO-APPLICATIONS OF INTRAOCULAR LENS 79
7.2.1.1 Carbon impact reduction 79
7.2.1.2 Eco-applications 79
?
7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 79
7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 80
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 81
8.1 DECISION-MAKING PROCESS 81
8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 81
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 81
8.2.2 KEY BUYING CRITERIA 82
8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 83
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 83
8.5 MARKET PROFITABILITY 84
8.5.1 REVENUE POTENTIAL 84
8.5.2 COST DYNAMICS 84
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 84
9 INTRAOCULAR LENS MARKET, BY TYPE 85
9.1 INTRODUCTION 86
9.2 MONOFOCAL INTRAOCULAR LENSES 86
9.2.1 ASPHERIC MONOFOCAL INTRAOCULAR LENSES 88
9.2.1.1 Increased visual quality and performance to propel market 88
9.2.2 SPHERIC MONOFOCAL INTRAOCULAR LENSES 90
9.2.2.1 Cost-effectiveness to drive market 90
9.3 PREMIUM INTRAOCULAR LENSES 91
9.3.1 MULTIFOCAL INTRAOCULAR LENSES 94
9.3.1.1 Enhanced visual acuity to support growth 94
9.3.2 EXTENDED DEPTH OF FOCUS (EDOF) INTRAOCULAR LENSES 95
9.3.2.1 Broader range of clear vision to drive market 95
9.3.3 ACCOMMODATING INTRAOCULAR LENSES 96
9.3.3.1 High utilization in cataract correction to aid growth 96
9.4 PHAKIC INTRAOCULAR LENSES 97
9.4.1 LIMITED AWARENESS AND COST CONCERNS TO RESTRAIN MARKET 97
9.5 OTHER INTRAOCULAR LENSES 99
10 INTRAOCULAR LENS MARKET, BY MATERIAL 100
10.1 INTRODUCTION 101
10.2 HYDROPHOBIC ACRYLIC IOL 101
10.2.1 INCREASED BIOCOMPATIBILITY AND HEIGHTENED STABILITY TO DRIVE MARKET 101
10.3 HYDROPHILIC ACRYLIC IOL 102
10.3.1 GLARE REDUCTION AND INCREASED COMPRESSIBILITY TO PROPEL MARKET 102
10.4 POLYMETHYLMETHACRYLATE 103
10.4.1 LOW MATERIAL COST AND ADVANCED DURABILITY TO BOOST MARKET 103
10.5 SILICONE IOL 105
10.5.1 LOW AWARENESS AND LIMITED FOLDABILITY TO RESTRAIN MARKET 105
10.6 OTHER MATERIALS 106
11 INTRAOCULAR LENS MARKET, BY APPLICATION 107
11.1 INTRODUCTION 108
11.2 CATARACT SURGERIES 108
11.2.1 RISING GERIATRIC POPULATION TO FACILITATE GROWTH 108
11.3 PRESBYOPIA 110
11.3.1 GROWING AWARENESS OF TECHNOLOGICALLY ADVANCED LENSES TO BOOST MARKET 110
11.4 CORNEAL DISORDERS 111
11.4.1 INCREASING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES TO SPUR GROWTH 111
11.5 OTHER APPLICATIONS 113
12 INTRAOCULAR LENS MARKET, BY END USER 114
12.1 INTRODUCTION 115
12.2 HOSPITALS 115
12.2.1 HIGH PURCHASING POWER FOR ADVANCED EQUIPMENT TO PROPEL MARKET 115
12.3 OPHTHALMOLOGY CLINICS 116
12.3.1 REDUCED WAITING TIME AND MINIMAL COST OF DIAGNOSTIC & SURGICAL PROCEDURES TO DRIVE MARKET 116
12.4 EYE RESEARCH INSTITUTES 118
12.4.1 INCREASING R&D ON INTRAOCULAR LENS TECHNOLOGIES TO ENCOURAGE GROWTH 118
12.5 OTHER END USERS 119
13 INTRAOCULAR LENS MARKET, BY REGION 120
13.1 INTRODUCTION 121
13.2 NORTH AMERICA 121
13.2.1 US 125
13.2.1.1 Favorable reimbursement policies to drive market 125
13.2.2 CANADA 127
13.2.2.1 Large target population to fuel market 127
13.3 EUROPE 130
13.3.1 GERMANY 132
13.3.1.1 Increasing public healthcare expenditure to aid growth 132
13.3.2 FRANCE 135
13.3.2.1 Government initiatives for visual care awareness to support growth 135
13.3.3 UK 138
13.3.3.1 Growing healthcare expenditure to facilitate growth 138
?
13.3.4 ITALY 140
13.3.4.1 Increasing R&D initiatives for eye care to spur growth 140
13.3.5 SPAIN 143
13.3.5.1 Rising healthcare spending to encourage growth 143
13.3.6 REST OF EUROPE 145
13.4 ASIA PACIFIC 148
13.4.1 JAPAN 151
13.4.1.1 Rising geriatric population to boost demand 151
13.4.2 CHINA 153
13.4.2.1 Improved healthcare infrastructure to support growth 153
13.4.3 INDIA 156
13.4.3.1 Rising number of cataract surgeries to drive market 156
13.4.4 AUSTRALIA 158
13.4.4.1 High focus on R&D for advanced IOLs to fuel market 158
13.4.5 SOUTH KOREA 160
13.4.5.1 Rising adoption of technologically advanced intraocular lenses to boost market 160
13.4.6 REST OF ASIA PACIFIC 163
13.5 LATIN AMERICA 165
13.5.1 BRAZIL 168
13.5.1.1 Government initiatives for healthcare infrastructure to boost market 168
13.5.2 MEXICO 170
13.5.2.1 Rising incidence of chronic diseases to support growth 170
13.5.3 REST OF LATIN AMERICA 172
13.6 MIDDLE EAST & AFRICA 175
13.6.1 EXPANDING ACCESS TO VISION CARE TO ACCELERATE GROWTH 175
13.7 GCC COUNTRIES 177
13.7.1 RISE IN CAMPAIGNS TO BOOST AWARENESS FOR CATARACT SURGERIES AND TREATMENT TO DRIVE MARKET 177
14 COMPETITIVE LANDSCAPE 180
14.1 OVERVIEW 180
14.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN 180
14.3 REVENUE ANALYSIS, 2020?2024 182
14.4 MARKET SHARE ANALYSIS, 2024 183
14.5 US MARKET SHARE ANALYSIS 184
14.6 BRAND/PRODUCT COMPARISON 186
14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 187
14.7.1 STARS 187
14.7.2 EMERGING LEADERS 187
14.7.3 PERVASIVE PLAYERS 187
14.7.4 PARTICIPANTS 187
?
14.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 189
14.7.5.1 Company footprint 189
14.7.5.2 Region footprint 190
14.7.5.3 Type footprint 191
14.7.5.4 Material footprint 192
14.7.5.5 Application footprint 193
14.7.5.6 End-user footprint 194
14.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 195
14.8.1 PROGRESSIVE COMPANIES 195
14.8.2 RESPONSIVE COMPANIES 195
14.8.3 DYNAMIC COMPANIES 195
14.8.4 STARTING BLOCKS 195
14.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 197
14.8.5.1 Detailed list of key startups/SMEs 197
14.8.5.2 Competitive benchmarking of key startups/SMEs 198
14.9 COMPANY VALUATION AND FINANCIAL METRICS 198
14.9.1 COMPANY VALUATION 198
14.9.2 FINANCIAL METRICS 199
14.10 COMPETITIVE SCENARIO 199
14.10.1 PRODUCT LAUNCHES AND APPROVALS 199
14.10.2 DEALS 201
14.10.3 EXPANSIONS 203
15 COMPANY PROFILES 204
15.1 KEY PLAYERS 204
15.1.1 ALCON 204
15.1.1.1 Business overview 204
15.1.1.2 Products offered 205
15.1.1.3 Recent developments 206
15.1.1.3.1 Product launches and approvals 206
15.1.1.3.2 Deals 206
15.1.1.4 MnM view 207
15.1.1.4.1 Key strengths/Right to win 207
15.1.1.4.2 Strategic choices 207
15.1.1.4.3 Weaknesses/Competitive threats 207
15.1.2 JOHNSON & JOHNSON VISION CARE, INC. 208
15.1.2.1 Business overview 208
15.1.2.2 Products offered 209
15.1.2.3 Recent developments 210
15.1.2.3.1 Product launches and approvals 210
?
15.1.2.4 MnM view 210
15.1.2.4.1 Key strengths/Right to win 210
15.1.2.4.2 Strategic choices 210
15.1.2.4.3 Weaknesses/Competitive threats 210
15.1.3 BAUSCH + LOMB 211
15.1.3.1 Business overview 211
15.1.3.2 Products offered 212
15.1.3.3 Recent developments 213
15.1.3.3.1 Product launches and approvals 213
15.1.3.3.2 Deals 213
15.1.3.4 MnM view 214
15.1.3.4.1 Key strengths/Right to win 214
15.1.3.4.2 Strategic choices 214
15.1.3.4.3 Weaknesses/Competitive threats 214
15.1.4 CARL ZEISS MEDITEC AG 215
15.1.4.1 Business overview 215
15.1.4.2 Products offered 216
15.1.4.3 Recent developments 216
15.1.4.3.1 Product launches and approvals 216
15.1.4.3.2 Deals 217
15.1.4.4 MnM view 217
15.1.4.4.1 Key strengths/Right to win 217
15.1.4.4.2 Strategic choices 217
15.1.4.4.3 Weaknesses/Competitive threats 217
15.1.5 HOYA CORPORATION 218
15.1.5.1 Business overview 218
15.1.5.2 Products offered 219
15.1.5.3 Recent developments 220
15.1.5.3.1 Deals 220
15.1.5.4 MnM view 220
15.1.5.4.1 Key strengths/Right to win 220
15.1.5.4.2 Strategic choices 220
15.1.5.4.3 Weaknesses/Competitive threats 220
15.1.6 SANTEN PHARMACEUTICAL CO., LTD. 221
15.1.6.1 Business overview 221
15.1.6.2 Products offered 222
15.1.7 NIDEK CO., LTD. 223
15.1.7.1 Business overview 223
15.1.7.2 Products offered 223
15.1.7.3 Recent developments 224
15.1.7.3.1 Deals 224
?
15.1.8 LENSTEC, INC. 225
15.1.8.1 Business overview 225
15.1.8.2 Products offered 225
15.1.8.3 Recent developments 225
15.1.8.3.1 Other developments 225
15.1.9 RAYNER GROUP 226
15.1.9.1 Business overview 226
15.1.9.2 Products offered 226
15.1.9.3 Recent developments 227
15.1.9.3.1 Product launches and approvals 227
15.1.10 BVI 228
15.1.10.1 Business overview 228
15.1.10.2 Products offered 228
15.1.10.3 Recent developments 229
15.1.10.3.1 Product launches and approvals 229
15.1.10.3.2 Expansions 229
15.1.11 OPHTEC B.V. 230
15.1.11.1 Business overview 230
15.1.11.2 Products offered 230
15.1.12 SAV-IOL SA 231
15.1.12.1 Business overview 231
15.1.12.2 Products offered 231
15.1.13 APPASAMY ASSOCIATES PRIVATE LIMITED 232
15.1.13.1 Business overview 232
15.1.13.2 Products offered 232
15.1.14 ATIA VISION, INC. 233
15.1.14.1 Business overview 233
15.1.14.2 Products offered 233
15.1.15 ADAPTILENS 234
15.1.15.1 Business overview 234
15.1.15.2 Products offered 234
15.2 OTHER PLAYERS 235
15.2.1 BIOTECH 235
15.2.2 TELEON SURGICAL BV 236
15.2.3 OMNI LENS PVT. LTD. 236
15.2.4 EYEKON MEDICAL 237
15.2.5 HUMANOPTICS HOLDING AG 237
15.2.6 CARE GROUP 238
15.2.7 SIFI S.P.A. 238
15.2.8 HANITA LENSES LTD. 239
15.2.9 EXCELLENT HI-CARE PVT LTD. 240
15.2.10 ADVIN HEALTH CARE 241
16 RESEARCH METHODOLOGY 242
16.1 RESEARCH DATA 242
16.1.1 SECONDARY DATA 242
16.1.1.1 Key data from secondary sources 244
16.1.2 PRIMARY DATA 244
16.1.2.1 Key data from primary sources 245
16.1.2.2 Key primary participants 246
16.1.2.3 Breakdown of primary interviews 246
16.1.2.4 Key industry insights 247
16.2 MARKET SIZE ESTIMATION 248
16.3 DATA TRIANGULATION 253
16.4 MARKET SHARE ESTIMATION 253
16.5 RESEARCH ASSUMPTIONS 254
16.6 RESEARCH LIMITATIONS AND RISK ASSESSMENT 254
16.6.1 RESEARCH LIMITATIONS 254
16.6.2 RISK ASSESSMENT 254
17 APPENDIX 255
17.1 DISCUSSION GUIDE 255
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 259
17.3 CUSTOMIZATION OPTIONS 261
17.4 RELATED REPORTS 261
17.5 AUTHOR DETAILS 262
ページTOPに戻る
List of Tables/Graphs
TABLE 1 INCLUSIONS AND EXCLUSIONS 27
TABLE 2 STANDARD CURRENCY CONVERSION RATES, 2020?2024 28
TABLE 3 INTRAOCULAR LENS MARKET: INTERCONNECTED MARKETS 45
TABLE 4 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 46
TABLE 5 INTRAOCULAR LENS MARKET: PORTER’S FIVE FORCES ANALYSIS 47
TABLE 6 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021?2030 50
TABLE 7 AVERAGE SELLING PRICE TREND OF INTRAOCULAR LENS,
BY KEY PLAYER, 2022?2024 (USD) 56
TABLE 8 AVERAGE PRICING TREND OF INTRAOCULAR LENS, BY REGION, 2022?2024 (USD) 57
TABLE 9 IMPORT DATA FOR INTRAOCULAR LENS PRODUCTS UNDER HS CODE 900290,
BY COUNTRY, 2020?2024 (USD THOUSAND) 58
TABLE 10 EXPORT DATA FOR INTRAOCULAR LENS UNDER HS CODE 900290,
BY COUNTRY, 2020?2024 (USD THOUSAND) 58
TABLE 11 INTRAOCULAR LENS MARKET: KEY CONFERENCES AND EVENTS, 2025?2027 59
TABLE 12 US-ADJUSTED RECIPROCAL TARIFF RATES 63
TABLE 13 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR INTRAOCULAR LENS 64
TABLE 14 INTRAOCULAR LENS MARKET: LIST OF PATENTS, 2022?2025 70
TABLE 15 TOP USE CASES AND MARKET POTENTIAL 73
TABLE 16 INTRAOCULAR LENS MARKET: CASE STUDIES RELATED TO AI IMPLEMENTATION 74
TABLE 17 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 75
TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 76
TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 76
TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 77
TABLE 21 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 77
TABLE 22 MIDDLE EAST & AFRICA AND GCC COUNTRIES: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 23 GLOBAL STANDARDS IN INTRAOCULAR LENS MARKET 78
TABLE 24 INTRAOCULAR LENS MARKET: CERTIFICATIONS, LABELING, AND ECO-STANDARDS 80
TABLE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR INTRAOCULAR LENS, BY APPLICATION 82
TABLE 26 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 82
TABLE 27 INTRAOCULAR LENS MARKET: UNMET NEEDS/END-USER EXPECTATIONS 83
TABLE 28 INTRAOCULAR LENS MARKET, BY TYPE, 2023?2030 (USD MILLION) 86
TABLE 29 MONOFOCAL INTRAOCULAR LENSES MARKET, BY TYPE,
2023?2030 (USD MILLION) 87
TABLE 30 MONOFOCAL INTRAOCULAR LENSES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 87
TABLE 31 MONOFOCAL INTRAOCULAR LENSES MARKET, BY COUNTRY,
2023?2030 (THOUSAND UNIT) 88
TABLE 32 ASPHERIC MONOFOCAL INTRAOCULAR LENSES MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 89
TABLE 33 SPHERIC MONOFOCAL INTRAOCULAR LENSES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 90
TABLE 34 PREMIUM INTRAOCULAR LENSES MARKET, BY TYPE, 2023?2030 (USD MILLION) 92
TABLE 35 PREMIUM INTRAOCULAR LENSES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 92
TABLE 36 PREMIUM INTRAOCULAR LENSES MARKET, BY COUNTRY,
2023?2030 (THOUSAND UNIT) 93
TABLE 37 MULTIFOCAL INTRAOCULAR LENSES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 94
TABLE 38 EXTENDED DEPTH OF FOCUS (EDOF) INTRAOCULAR LENSES MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 95
TABLE 39 ACCOMMODATING INTRAOCULAR LENSES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 96
TABLE 40 PHAKIC INTRAOCULAR LENSES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 97
TABLE 41 PHAKIC INTRAOCULAR LENSES MARKET, BY COUNTRY,
2023?2030 (THOUSAND UNIT) 98
TABLE 42 OTHER INTRAOCULAR LENSES MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 99
TABLE 43 INTRAOCULAR LENS MARKET, BY MATERIAL, 2023?2030 (USD MILLION) 101
TABLE 44 INTRAOCULAR LENS MARKET FOR HYDROPHOBIC ACRYLIC IOL,
BY COUNTRY, 2023?2030 (USD MILLION) 102
TABLE 45 INTRAOCULAR LENS MARKET FOR HYDROPHILIC ACRYLIC IOL,
BY COUNTRY, 2023?2030 (USD MILLION) 103
TABLE 46 INTRAOCULAR LENS MARKET FOR POLYMETHYLMETHACRYLATE,
BY COUNTRY, 2023?2030 (USD MILLION) 104
TABLE 47 INTRAOCULAR LENS MARKET FOR SILICONE IOL, BY COUNTRY,
2023?2030 (USD MILLION) 105
TABLE 48 INTRAOCULAR LENS MARKET FOR OTHER MATERIALS, BY COUNTRY,
2023?2030 (USD MILLION) 106
TABLE 49 INTRAOCULAR LENS MARKET, BY APPLICATION, 2023?2030 (USD MILLION) 108
TABLE 50 INTRAOCULAR LENS MARKET FOR CATARACT SURGERIES,
BY COUNTRY, 2023?2030 (USD MILLION) 110
TABLE 51 INTRAOCULAR LENS MARKET FOR PRESBYOPIA, BY COUNTRY,
2023?2030 (USD MILLION) 111
TABLE 52 INTRAOCULAR LENS MARKET FOR CORNEAL DISORDERS,
BY COUNTRY, 2023?2030 (USD MILLION) 112
TABLE 53 INTRAOCULAR LENS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2023?2030 (USD MILLION) 113
TABLE 54 INTRAOCULAR LENS MARKET, BY END USER, 2023?2030 (USD MILLION) 115
TABLE 55 INTRAOCULAR LENS MARKET FOR HOSPITALS, BY COUNTRY,
2023?2030 (USD MILLION) 116
TABLE 56 INTRAOCULAR LENS MARKET FOR CLINICS, BY COUNTRY,
2023?2030 (USD MILLION) 117
TABLE 57 INTRAOCULAR LENS MARKET FOR EYE RESEARCH INSTITUTES,
BY COUNTRY, 2023?2030 (USD MILLION) 118
TABLE 58 INTRAOCULAR LENS MARKET FOR OTHER END USERS, BY COUNTRY,
2023?2030 (USD MILLION) 119
TABLE 59 INTRAOCULAR LENS MARKET, BY REGION, 2023?2030 (USD MILLION) 121
TABLE 60 NORTH AMERICA: INTRAOCULAR LENS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 122
TABLE 61 NORTH AMERICA: INTRAOCULAR LENS MARKET, BY TYPE,
2023?2030 (USD MILLION) 123
TABLE 62 NORTH AMERICA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL,
BY TYPE,2023?2030 (USD MILLION) 123
TABLE 63 NORTH AMERICA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL,
BY TYPE, 2023?2030 (USD MILLION) 123
TABLE 64 NORTH AMERICA: INTRAOCULAR LENS MARKET, BY MATERIAL,
2023?2030 (USD MILLION) 124
TABLE 65 NORTH AMERICA: INTRAOCULAR LENS MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 124
TABLE 66 NORTH AMERICA: INTRAOCULAR LENS MARKET, BY END USER,
2023?2030 (USD MILLION) 124
TABLE 67 US: INTRAOCULAR LENS MARKET, BY TYPE, 2023?2030 (USD MILLION) 125
TABLE 68 US: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL,
BY TYPE, 2023?2030 (USD MILLION) 126
TABLE 69 US: INTRAOCULAR LENS MARKET FOR PREMIUM IOL,
BY TYPE, 2023?2030 (USD MILLION) 126
TABLE 70 US: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023?2030 (USD MILLION) 126
TABLE 71 US: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023?2030 (USD MILLION) 127
TABLE 72 US: INTRAOCULAR LENS MARKET, BY END USER, 2023?2030 (USD MILLION) 127
TABLE 73 CANADA: INTRAOCULAR LENS MARKET, BY TYPE, 2023?2030 (USD MILLION) 128
TABLE 74 CANADA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL,
BY TYPE, 2023?2030 (USD MILLION) 128
TABLE 75 CANADA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL,
BY TYPE, 2023?2030 (USD MILLION) 128
TABLE 76 CANADA: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023?2030 (USD MILLION) 129
TABLE 77 CANADA: INTRAOCULAR LENS MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 129
TABLE 78 CANADA: INTRAOCULAR LENS MARKET, BY END USER, 2023?2030 (USD MILLION) 129
TABLE 79 EUROPE: INTRAOCULAR LENS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 130
TABLE 80 EUROPE: INTRAOCULAR LENS MARKET, BY TYPE, 2023?2030 (USD MILLION) 130
TABLE 81 EUROPE: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL,
BY TYPE, 2023?2030 (USD MILLION) 131
TABLE 82 EUROPE: INTRAOCULAR LENS MARKET FOR PREMIUM IOL,
BY TYPE, 2023?2030 (USD MILLION) 131
TABLE 83 EUROPE: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023?2030 (USD MILLION) 131
TABLE 84 EUROPE: INTRAOCULAR LENS MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 132
TABLE 85 EUROPE: INTRAOCULAR LENS MARKET, BY END USER, 2023?2030 (USD MILLION) 132
TABLE 86 GERMANY: INTRAOCULAR LENS MARKET, BY TYPE, 2023?2030 (USD MILLION) 133
TABLE 87 GERMANY: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL,
BY TYPE, 2023?2030 (USD MILLION) 133
TABLE 88 GERMANY: INTRAOCULAR LENS MARKET FOR PREMIUM IOL,
BY TYPE, 2023?2030 (USD MILLION) 133
TABLE 89 GERMANY: INTRAOCULAR LENS MARKET, BY MATERIAL,
2023?2030 (USD MILLION) 134
TABLE 90 GERMANY: INTRAOCULAR LENS MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 134
TABLE 91 GERMANY: INTRAOCULAR LENS MARKET, BY END USER,
2023?2030 (USD MILLION) 134
TABLE 92 FRANCE: INTRAOCULAR LENS MARKET, BY TYPE, 2023?2030 (USD MILLION) 136
TABLE 93 FRANCE: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL,
BY TYPE, 2023?2030 (USD MILLION) 136
TABLE 94 FRANCE: INTRAOCULAR LENS MARKET FOR PREMIUM IOL,
BY TYPE, 2023?2030 (USD MILLION) 137
TABLE 95 FRANCE: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023?2030 (USD MILLION) 137
TABLE 96 FRANCE: INTRAOCULAR LENS MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 137
TABLE 97 FRANCE: INTRAOCULAR LENS MARKET, BY END USER, 2023?2030 (USD MILLION) 138
TABLE 98 UK: INTRAOCULAR LENS MARKET, BY TYPE, 2023?2030 (USD MILLION) 138
TABLE 99 UK: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL,
BY TYPE, 2023?2030 (USD MILLION) 139
TABLE 100 UK: INTRAOCULAR LENS MARKET FOR PREMIUM IOL, BY TYPE,
2023?2030 (USD MILLION) 139
TABLE 101 UK: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023?2030 (USD MILLION) 139
TABLE 102 UK: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023?2030 (USD MILLION) 140
TABLE 103 UK: INTRAOCULAR LENS MARKET, BY END USER, 2023?2030 (USD MILLION) 140
TABLE 104 ITALY: INTRAOCULAR LENS MARKET, BY TYPE, 2023?2030 (USD MILLION) 141
TABLE 105 ITALY: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL,
BY TYPE, 2023?2030 (USD MILLION) 141
TABLE 106 ITALY: INTRAOCULAR LENS MARKET FOR PREMIUM IOL,
BY TYPE, 2023?2030 (USD MILLION) 141
TABLE 107 ITALY: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023?2030 (USD MILLION) 142
TABLE 108 ITALY: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023?2030 (USD MILLION) 142
TABLE 109 ITALY: INTRAOCULAR LENS MARKET, BY END USER, 2023?2030 (USD MILLION) 142
TABLE 110 SPAIN: INTRAOCULAR LENS MARKET, BY TYPE, 2023?2030 (USD MILLION) 143
TABLE 111 SPAIN: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL,
BY TYPE, 2023?2030 (USD MILLION) 143
TABLE 112 SPAIN: INTRAOCULAR LENS MARKET FOR PREMIUM IOL,
BY TYPE, 2023?2030 (USD MILLION) 144
TABLE 113 SPAIN: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023?2030 (USD MILLION) 144
TABLE 114 SPAIN: INTRAOCULAR LENS MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 144
TABLE 115 SPAIN: INTRAOCULAR LENS MARKET, BY END USER, 2023?2030 (USD MILLION) 145
TABLE 116 REST OF EUROPE: INTRAOCULAR LENS MARKET, BY TYPE,
2023?2030 (USD MILLION) 145
TABLE 117 REST OF EUROPE: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL,
BY TYPE, 2023?2030 (USD MILLION) 146
TABLE 118 REST OF EUROPE: INTRAOCULAR LENS MARKET FOR PREMIUM IOL,
BY TYPE, 2023?2030 (USD MILLION) 146
TABLE 119 REST OF EUROPE: INTRAOCULAR LENS MARKET, BY MATERIAL,
2023?2030 (USD MILLION) 146
TABLE 120 REST OF EUROPE: INTRAOCULAR LENS MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 147
TABLE 121 REST OF EUROPE: INTRAOCULAR LENS MARKET, BY END USER,
2023?2030 (USD MILLION) 147
TABLE 122 ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 149
TABLE 123 ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY TYPE, 2023?2030 (USD MILLION) 149
TABLE 124 ASIA PACIFIC: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL,
BY TYPE, 2023?2030 (USD MILLION) 149
TABLE 125 ASIA PACIFIC: INTRAOCULAR LENS MARKET FOR PREMIUM IOL,
BY TYPE, 2023?2030 (USD MILLION) 150
TABLE 126 ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY MATERIAL,
2023?2030 (USD MILLION) 150
TABLE 127 ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 150
TABLE 128 ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY END USER,
2023?2030 (USD MILLION) 151
TABLE 129 JAPAN: INTRAOCULAR LENS MARKET, BY TYPE, 2023?2030 (USD MILLION) 151
TABLE 130 JAPAN: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL,
BY TYPE, 2023?2030 (USD MILLION) 152
TABLE 131 JAPAN: INTRAOCULAR LENS MARKET FOR PREMIUM IOL,
BY TYPE, 2023?2030 (USD MILLION) 152
TABLE 132 JAPAN: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023?2030 (USD MILLION) 152
TABLE 133 JAPAN: INTRAOCULAR LENS MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 153
TABLE 134 JAPAN: INTRAOCULAR LENS MARKET, BY END USER, 2023?2030 (USD MILLION) 153
TABLE 135 CHINA: INTRAOCULAR LENS MARKET, BY TYPE, 2023?2030 (USD MILLION) 154
TABLE 136 CHINA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL,
BY TYPE, 2023?2030 (USD MILLION) 154
TABLE 137 CHINA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL,
BY TYPE, 2023?2030 (USD MILLION) 154
TABLE 138 CHINA: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023?2030 (USD MILLION) 155
TABLE 139 CHINA: INTRAOCULAR LENS MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 155
TABLE 140 CHINA: INTRAOCULAR LENS MARKET, BY END USER, 2023?2030 (USD MILLION) 155
TABLE 141 INDIA: INTRAOCULAR LENS MARKET, BY TYPE, 2023?2030 (USD MILLION) 156
TABLE 142 INDIA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL,
BY TYPE, 2023?2030 (USD MILLION) 156
TABLE 143 INDIA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL,
BY TYPE, 2023?2030 (USD MILLION) 157
TABLE 144 INDIA: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023?2030 (USD MILLION) 157
TABLE 145 INDIA: INTRAOCULAR LENS MARKET, BY APPLICATION, 2023?2030 (USD MILLION) 157
TABLE 146 INDIA: INTRAOCULAR LENS MARKET, BY END USER, 2023?2030 (USD MILLION) 158
TABLE 147 AUSTRALIA: INTRAOCULAR LENS MARKET, BY TYPE, 2023?2030 (USD MILLION) 158
TABLE 148 AUSTRALIA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL,
BY TYPE, 2023?2030 (USD MILLION) 159
TABLE 149 AUSTRALIA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL,
BY TYPE, 2023?2030 (USD MILLION) 159
TABLE 150 AUSTRALIA: INTRAOCULAR LENS MARKET, BY MATERIAL,
2023?2030 (USD MILLION) 159
TABLE 151 AUSTRALIA: INTRAOCULAR LENS MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 160
TABLE 152 AUSTRALIA: INTRAOCULAR LENS MARKET, BY END USER,
2023?2030 (USD MILLION) 160
TABLE 153 SOUTH KOREA: INTRAOCULAR LENS MARKET, BY TYPE,
2023?2030 (USD MILLION) 161
TABLE 154 SOUTH KOREA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL,
BY TYPE, 2023?2030 (USD MILLION) 161
TABLE 155 SOUTH KOREA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL,
BY TYPE, 2023?2030 (USD MILLION) 161
TABLE 156 SOUTH KOREA: INTRAOCULAR LENS MARKET, BY MATERIAL,
2023?2030 (USD MILLION) 162
TABLE 157 SOUTH KOREA: INTRAOCULAR LENS MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 162
TABLE 158 SOUTH KOREA: INTRAOCULAR LENS MARKET, BY END USER,
2023?2030 (USD MILLION) 162
TABLE 159 REST OF ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY TYPE,
2023?2030 (USD MILLION) 163
TABLE 160 REST OF ASIA PACIFIC: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL,
BY TYPE, 2023?2030 (USD MILLION) 163
TABLE 161 REST OF ASIA PACIFIC: INTRAOCULAR LENS MARKET FOR PREMIUM IOL,
BY TYPE, 2023?2030 (USD MILLION) 164
TABLE 162 REST OF ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY MATERIAL,
2023?2030 (USD MILLION) 164
TABLE 163 REST OF ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 164
TABLE 164 REST OF ASIA PACIFIC: INTRAOCULAR LENS MARKET, BY END USER,
2023?2030 (USD MILLION) 165
TABLE 165 LATIN AMERICA: INTRAOCULAR LENS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 165
TABLE 166 LATIN AMERICA: INTRAOCULAR LENS MARKET, BY TYPE,
2023?2030 (USD MILLION) 166
TABLE 167 LATIN AMERICA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL,
BY TYPE, 2023?2030 (USD MILLION) 166
TABLE 168 LATIN AMERICA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL,
BY TYPE, 2023?2030 (USD MILLION) 166
TABLE 169 LATIN AMERICA: INTRAOCULAR LENS MARKET, BY MATERIAL,
2023?2030 (USD MILLION) 167
TABLE 170 LATIN AMERICA: INTRAOCULAR LENS MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 167
TABLE 171 LATIN AMERICA: INTRAOCULAR LENS MARKET, BY END USER,
2023?2030 (USD MILLION) 167
TABLE 172 BRAZIL: INTRAOCULAR LENS MARKET, BY TYPE, 2023?2030 (USD MILLION) 168
TABLE 173 BRAZIL: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL,
BY TYPE, 2023?2030 (USD MILLION) 168
TABLE 174 BRAZIL: INTRAOCULAR LENS MARKET FOR PREMIUM IOL,
BY TYPE, 2023?2030 (USD MILLION) 169
TABLE 175 BRAZIL: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023?2030 (USD MILLION) 169
TABLE 176 BRAZIL: INTRAOCULAR LENS MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 169
TABLE 177 BRAZIL: INTRAOCULAR LENS MARKET, BY END USER, 2023?2030 (USD MILLION) 170
TABLE 178 MEXICO: INTRAOCULAR LENS MARKET, BY TYPE, 2023?2030 (USD MILLION) 170
TABLE 179 MEXICO: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL,
BY TYPE, 2023?2030 (USD MILLION) 171
TABLE 180 MEXICO: INTRAOCULAR LENS MARKET FOR PREMIUM IOL,
BY TYPE, 2023?2030 (USD MILLION) 171
TABLE 181 MEXICO: INTRAOCULAR LENS MARKET, BY MATERIAL, 2023?2030 (USD MILLION) 171
TABLE 182 MEXICO: INTRAOCULAR LENS MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 172
TABLE 183 MEXICO: INTRAOCULAR LENS MARKET, BY END USER, 2023?2030 (USD MILLION) 172
TABLE 184 REST OF LATIN AMERICA: INTRAOCULAR LENS MARKET,
BY TYPE, 2023?2030 (USD MILLION) 173
TABLE 185 REST OF LATIN AMERICA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL,
BY TYPE,2023?2030 (USD MILLION) 173
TABLE 186 REST OF LATIN AMERICA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL,
BY TYPE,2023?2030 (USD MILLION) 173
TABLE 187 REST OF LATIN AMERICA: INTRAOCULAR LENS MARKET, BY MATERIAL,
2023?2030 (USD MILLION) 174
TABLE 188 REST OF LATIN AMERICA: INTRAOCULAR LENS MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 174
TABLE 189 REST OF LATIN AMERICA: INTRAOCULAR LENS MARKET, BY END USER,
2023?2030 (USD MILLION) 174
TABLE 190 MIDDLE EAST & AFRICA: INTRAOCULAR LENS MARKET, BY TYPE,
2023?2030 (USD MILLION) 175
TABLE 191 MIDDLE EAST & AFRICA: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL,
BY TYPE, 2023?2030 (USD MILLION) 175
TABLE 192 MIDDLE EAST & AFRICA: INTRAOCULAR LENS MARKET FOR PREMIUM IOL,
BY TYPE, 2023?2030 (USD MILLION) 176
TABLE 193 MIDDLE EAST & AFRICA: INTRAOCULAR LENS MARKET, BY MATERIAL,
2023?2030 (USD MILLION) 176
TABLE 194 MIDDLE EAST & AFRICA: INTRAOCULAR LENS MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 176
TABLE 195 MIDDLE EAST & AFRICA: INTRAOCULAR LENS MARKET, BY END USER,
2023?2030 (USD MILLION) 177
TABLE 196 GCC COUNTRIES: INTRAOCULAR LENS MARKET, BY TYPE,
2023?2030 (USD MILLION) 178
TABLE 197 GCC COUNTRIES: INTRAOCULAR LENS MARKET FOR MONOFOCAL IOL,
BY TYPE, 2023?2030 (USD MILLION) 178
TABLE 198 GCC COUNTRIES: INTRAOCULAR LENS MARKET FOR PREMIUM IOL,
BY TYPE, 2023?2030 (USD MILLION) 178
TABLE 199 GCC COUNTRIES: INTRAOCULAR LENS MARKET, BY MATERIAL,
2023?2030 (USD MILLION) 179
TABLE 200 GCC COUNTRIES: INTRAOCULAR LENS MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 179
TABLE 201 GCC COUNTRIES: INTRAOCULAR LENS MARKET, BY END USER,
2023?2030 (USD MILLION) 179
TABLE 202 KEY DEVELOPMENTS IN INTRAOCULAR LENS MARKET,
JANUARY 2021?NOVEMBER 2025 180
TABLE 203 INTRAOCULAR LENS MARKET: DEGREE OF COMPETITION 184
TABLE 204 US INTRAOCULAR LENS MARKET: DEGREE OF COMPETITION 185
TABLE 205 INTRAOCULAR LENS MARKET: REGION FOOTPRINT 190
?
TABLE 206 INTRAOCULAR LENS MARKET: TYPE FOOTPRINT 191
TABLE 207 INTRAOCULAR LENS MARKET: MATERIAL FOOTPRINT 192
TABLE 208 INTRAOCULAR LENS MARKET: APPLICATION FOOTPRINT 193
TABLE 209 INTRAOCULAR LENS MARKET: END-USER FOOTPRINT 194
TABLE 210 INTRAOCULAR LENS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 197
TABLE 211 INTRAOCULAR LENS MARKET: COMPETITIVE BENCHMARKING OF
KEY STARTUPS/SMES 198
TABLE 212 INTRAOCULAR LENS MARKET: PRODUCT LAUNCHES,
JANUARY 2021?NOVEMBER 2025 199
TABLE 213 INTRAOCULAR LENS MARKET: DEALS, JANUARY 2021?NOVEMBER 2025 201
TABLE 214 INTRAOCULAR LENS MARKET: EXPANSIONS, JANUARY 2021?NOVEMBER 2025 203
TABLE 215 ALCON: COMPANY OVERVIEW 204
TABLE 216 ALCON: PRODUCTS OFFERED 205
TABLE 217 ALCON: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021?NOVEMBER 2025 206
TABLE 218 ALCON: DEALS, JANUARY 2021?NOVEMBER 2025 206
TABLE 219 JOHNSON & JOHNSON VISION CARE, INC.: COMPANY OVERVIEW 208
TABLE 220 JOHNSON & JOHNSON VISION CARE, INC.: PRODUCTS OFFERED 209
TABLE 221 JOHNSON & JOHNSON VISION CARE, INC.: PRODUCT LAUNCHES AND
APPROVALS, JANUARY 2021?OCTOBER 2025 210
TABLE 222 BAUSCH + LOMB: COMPANY OVERVIEW 211
TABLE 223 BAUSCH + LOMB: PRODUCTS OFFERED 212
TABLE 224 BAUSCH + LOMB: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2021?NOVEMBER 2025 213
TABLE 225 BAUSCH + LOMB: DEALS, JANUARY 2021?NOVEMBER 2025 213
TABLE 226 CARL ZEISS MEDITEC AG: COMPANY OVERVIEW 215
TABLE 227 CARL ZEISS MEDITEC AG: PRODUCTS OFFERED 216
TABLE 228 CARL ZEISS MEDITEC AG: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2021?NOVEMBER 2025 216
TABLE 229 CARL ZEISS MEDITEC AG: DEALS, JANUARY 2021?NOVEMBER 2025 217
TABLE 230 HOYA CORPORATION: COMPANY OVERVIEW 218
TABLE 231 HOYA CORPORATION: PRODUCTS OFFERED 219
TABLE 232 HOYA CORPORATION: DEALS, JANUARY 2021?NOVEMBER 2025 220
TABLE 233 SANTEN PHARMACEUTICAL CO., LTD.: COMPANY OVERVIEW 221
TABLE 234 SANTEN PHARMACEUTICAL CO., LTD.: PRODUCTS OFFERED 222
TABLE 235 NIDEK CO., LTD.: COMPANY OVERVIEW 223
TABLE 236 NIDEK CO., LTD.: PRODUCTS OFFERED 223
TABLE 237 NIDEK CO., LTD.: DEALS, JANUARY 2021?NOVEMBER 2025 224
TABLE 238 LENSTEC, INC.: COMPANY OVERVIEW 225
TABLE 239 LENSTEC, INC.: PRODUCTS OFFERED 225
TABLE 240 LENSTEC, INC.: OTHER DEVELOPMENTS, JANUARY 2021?NOVEMBER 2025 225
TABLE 241 RAYNER GROUP: COMPANY OVERVIEW 226
TABLE 242 RAYNER GROUP: PRODUCTS OFFERED 226
TABLE 243 RAYNER GROUP: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2021?NOVEMBER 2025 227
?
TABLE 244 BVI: COMPANY OVERVIEW 228
TABLE 245 BVI: PRODUCTS OFFERED 228
TABLE 246 BVI: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021?NOVEMBER 2025 229
TABLE 247 BVI: DEALS, JANUARY 2021?NOVEMBER 2025 229
TABLE 248 BVI: EXPANSIONS, JANUARY 2021?NOVEMBER 2025 229
TABLE 249 OPHTEC B.V.: COMPANY OVERVIEW 230
TABLE 250 OPHTEC B.V.: PRODUCTS OFFERED 230
TABLE 251 SAV-IOL SA: COMPANY OVERVIEW 231
TABLE 252 SAV-IOL SA: PRODUCTS OFFERED 231
TABLE 253 APPASAMY ASSOCIATES PRIVATE LIMITED: COMPANY OVERVIEW 232
TABLE 254 APPASAMY ASSOCIATES PRIVATE LIMITED: PRODUCTS OFFERED 232
TABLE 255 ATIA VISION, INC.: COMPANY OVERVIEW 233
TABLE 256 ATIA VISION, INC.: PRODUCTS OFFERED 233
TABLE 257 ADAPTILENS: COMPANY OVERVIEW 234
TABLE 258 ADAPTILENS: PRODUCTS OFFERED 234
TABLE 259 BIOTECH: COMPANY OVERVIEW 235
TABLE 260 TELEON SURGICAL BV: COMPANY OVERVIEW 236
TABLE 261 OMNI LENS PVT. LTD.: COMPANY OVERVIEW 236
TABLE 262 EYEKON MEDICAL: COMPANY OVERVIEW 237
TABLE 263 HUMANOPTICS HOLDING AG: COMPANY OVERVIEW 237
TABLE 264 CARE GROUP: COMPANY OVERVIEW 238
TABLE 265 SIFI S.P.A.: COMPANY OVERVIEW 238
TABLE 266 HANITA LENSES LTD.: COMPANY OVERVIEW 239
TABLE 267 EXCELLENT HI-CARE PVT. LTD.: COMPANY OVERVIEW 240
TABLE 268 ADVIN HEALTH CARE: COMPANY OVERVIEW 241
TABLE 269 INTRAOCULAR LENS MARKET: RESEARCH ASSUMPTIONS 254
TABLE 270 INTRAOCULAR LENS MARKET: RISK ASSESSMENT 254FIGURE 1 INTRAOCULAR LENS MARKET SEGMENTATION AND REGIONAL SCOPE 26
FIGURE 2 MARKET SCENARIO 30
FIGURE 3 INTRAOCULAR LENS MARKET, 2025?2030 30
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN INTRAOCULAR LENS
MARKET (2020?2025) 31
FIGURE 5 DISRUPTIVE TRENDS INFLUENCING GROWTH OF INTRAOCULAR LENS MARKET 32
FIGURE 6 HIGH-GROWTH SEGMENTS IN INTRAOCULAR LENS MARKET 33
FIGURE 7 NORTH AMERICA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 34
FIGURE 8 INCREASING INCIDENCE OF CHRONIC DISEASES AND SUBSEQUENT RISE IN CATARACT SURGERIES TO DRIVE MARKET 35
FIGURE 9 HOSPITALS SEGMENT AND CHINA LED ASIA PACIFIC MARKET IN 2024 36
FIGURE 10 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 37
FIGURE 11 NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 37
FIGURE 12 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 38
FIGURE 13 INTRAOCULAR LENS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 39
FIGURE 14 GLOBAL DISTANCE VISION IMPAIRMENT STATISTICS, 2023 41
FIGURE 15 INTRAOCULAR LENS MARKET: PORTER’S FIVE FORCES ANALYSIS 48
FIGURE 16 INTRAOCULAR LENS MARKET: SUPPLY CHAIN ANALYSIS 53
FIGURE 17 INTRAOCULAR LENS MARKET: VALUE CHAIN ANALYSIS 53
FIGURE 18 INTRAOCULAR LENS MARKET: ECOSYSTEM ANALYSIS 55
FIGURE 19 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN INTRAOCULAR LENS MARKET 60
FIGURE 20 INTRAOCULAR LENS MARKET: INVESTMENT AND FUNDING SCENARIO 60
FIGURE 21 INTRAOCULAR LENS MARKET: PATENT ANALYSIS,
JANUARY 2015?NOVEMBER 2025 69
FIGURE 22 TOP APPLICANTS FOR INTRAOCULAR LENS, BY COUNTRY/REGION,
JANUARY 2015? NOVEMBER 2025 70
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR INTRAOCULAR LENS, BY APPLICATION 81
FIGURE 24 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 82
FIGURE 25 NORTH AMERICA: INTRAOCULAR LENS MARKET SNAPSHOT 122
FIGURE 26 ASIA PACIFIC: INTRAOCULAR LENS MARKET SNAPSHOT 148
FIGURE 27 REVENUE ANALYSIS OF TOP PLAYERS IN INTRAOCULAR LENS MARKET,
2020?2024 (USD MILLION) 182
FIGURE 28 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 183
FIGURE 29 US MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 184
FIGURE 30 INTRAOCULAR LENS MARKET: BRAND/PRODUCT COMPARISON 186
FIGURE 31 INTRAOCULAR LENS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 188
?
FIGURE 32 INTRAOCULAR LENS MARKET: COMPANY FOOTPRINT 189
FIGURE 33 INTRAOCULAR LENS MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2024 196
FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF
KEY VENDORS 198
FIGURE 35 EV/EBITDA OF KEY VENDORS 199
FIGURE 36 ALCON: COMPANY SNAPSHOT (2024) 205
FIGURE 37 JOHNSON & JOHNSON VISION CARE, INC.: COMPANY SNAPSHOT (2024) 209
FIGURE 38 BAUSCH + LOMB: COMPANY SNAPSHOT (2024) 212
FIGURE 39 CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT (2024) 215
FIGURE 40 HOYA CORPORATION: COMPANY SNAPSHOT (2024) 219
FIGURE 41 SANTEN PHARMACEUTICAL CO., LTD.: COMPANY SNAPSHOT (2024) 221
FIGURE 42 RESEARCH DESIGN 242
FIGURE 43 PRIMARY SOURCES 244
FIGURE 44 KEY PRIMARY INTERVIEWS: SUPPLY/DEMAND-SIDE PARTICIPANTS 246
FIGURE 45 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 246
FIGURE 46 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE):
BY END USER, DESIGNATION, AND REGION 247
FIGURE 47 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 248
FIGURE 48 REVENUE SHARE ANALYSIS ILLUSTRATION: ALCON, INC. 249
FIGURE 49 SUPPLY-SIDE ANALYSIS OF TOP COMPANIES (2024) 249
FIGURE 50 INTRAOCULAR LENS MARKET: TOP-DOWN APPROACH 250
FIGURE 51 DEMAND-SIDE MARKET ESTIMATION FOR INTRAOCULAR LENSES 251
FIGURE 52 INTRAOCULAR LENS MARKET: CAGR PROJECTIONS OF DRIVERS,
RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023?2030) 252
FIGURE 53 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 252
FIGURE 54 DATA TRIANGULATION 253
